Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
7.8 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Pharmaceutical processors; permits processors to produce & distribute cannabis products. | Pharmaceutical processors; cannabis products.Permits pharmaceutical processors to produce and distribute cannabisproducts other than cannabis oil. The bill defines the terms "botanicalcannabis," "cannabis product," and "usable cannabis." The bill requiresthe Board of Pharmacy to establish testing standards for botanical cannabis and botanical cannabis products, establish a registrationprocess for botanical cannabis products, and promulgate emergency regulations to implement the provisions of the bill. The bill allowsthe Board of Pharmacy to assess and collect a one-time botanicalcannabis regulatory fee from each pharmaceutical processor, not toexceed $50,000, to cover costs associated with the implementationof the provisions of the bill, including costs for new personnel,training, promulgation of regulations and guidance documents, andinformation technology. | us/states/va | Virginia General Assembly | 2021 | SB 1333 | Virginia SB 1333 (2021) |
|
enacted |
|
6 | 47 | 8 | 2021-01-12 | 2021-03-18 | openstates | ocd-bill/1dd12eca-aa41-4a3c-a0d3-363f9519763c | https://lis.virginia.gov/cgi-bin/legp604.exe?212+sum+SB1333 | e9b93fd3f9f4922425d7358d9161fad29f7651b8efd71d4bbe45eba073450c43 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 1333 (2021) — Pharmaceutical processors; permits processors to produce & distribute cannabis products.
Pharmaceutical processors; cannabis products.Permits pharmaceutical processors to produce and distribute cannabisproducts other than cannabis oil. The bill defines the terms "botanicalcannabis," "cannabis product," and "usable cannabis." The bill requiresthe Board of Pharmacy to establish testing standards for botanical cannabis and botanical cannabis products, establish a registrationprocess for botanical cannabis products, and promulgate emergency regulations to implement the provisions of the bill. The bill allowsthe Board of Pharmacy to assess and collect a one-time botanicalcannabis regulatory fee from each pharmaceutical processor, not toexceed $50,000, to cover costs associated with the implementationof the provisions of the bill, including costs for new personnel,training, promulgation of regulations and guidance documents, andinformation technology.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0228 (committee substitute) — source
- Committee substitute printed 21103698D-S1 (committee substitute) — source
- Committee substitute printed 21104258D-S2 (committee substitute) — source
- Committee substitute printed 21104492D-H1 (committee substitute) — source
- Prefiled and ordered printed; offered 01/13/21 21102491D (committee substitute) — source
- SB1333ER (committee substitute) — source
Votes
- Read third time and passed Senate (32-Y 5-N) — 32–5 (pass) · upper
- House substitute agreed to by Senate (34-Y 5-N) — 34–5 (pass) · upper
- Reported from Finance and Appropriations with substitute (15-Y 0-N) — 15–0 (pass) · upper
- Reported from Education and Health with substitute (13-Y 1-N 1-A) — 13–1 (pass) · upper
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
- Reported from Health, Welfare and Institutions with substitute (21-Y 0-N) — 21–0 (pass) · lower
- VOTE: Passage (87-Y 9-N 2-A) — 86–9 (pass) · lower
- Continued to Special Session 1 in Health, Welfare and Institutions — 0–0 (fail) · lower
Sponsors
- L. Louise Lucas — primary (person)
- Adam P. Ebbin — cosponsor (person)
- Jeremy S. McPike — cosponsor (person)
- Joseph D. Morrissey — cosponsor (person)
- Siobhan S. Dunnavant — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-01-12 Prefiled and ordered printed; offered 01/13/21 21102491D
introduction - 2021-01-12 Referred to Committee on Education and Health
referral-committee - 2021-01-22 Assigned Education sub: Health
referral-committee - 2021-01-27 Impact statement from DPB (SB1333)
- 2021-01-28 Senate committee, floor amendments and substitutes offered
- 2021-01-28 Reported from Education and Health with substitute (13-Y 1-N 1-A)
committee-passage - 2021-01-28 Committee substitute printed 21103698D-S1
substitution - 2021-01-28 Rereferred to Finance and Appropriations
referral-committee - 2021-01-29 Impact statement from DPB (SB1333S1)
- 2021-02-01 Senate subcommittee amendments and substitutes offered
- 2021-02-03 Senate committee, floor amendments and substitutes offered
- 2021-02-03 Reported from Finance and Appropriations with substitute (15-Y 0-N)
committee-passage - 2021-02-03 Committee substitute printed 21104258D-S2
substitution - 2021-02-03 Constitutional reading dispensed (39-Y 0-N)
- 2021-02-04 Impact statement from DPB (SB1333S2)
- 2021-02-04 Read second time
reading-2 - 2021-02-04 Reading of substitute waived
- 2021-02-04 Committee substitute rejected 21103698D-S1
- 2021-02-04 Reading of substitute waived
- 2021-02-04 Committee substitute agreed to 21104258D-S2
- 2021-02-04 Engrossed by Senate - committee substitute SB1333S2
- 2021-02-05 Passed by temporarily
- 2021-02-05 Read third time and passed Senate (32-Y 5-N)
passage, reading-3 - 2021-02-07 Placed on Calendar
- 2021-02-07 Read first time
reading-1 - 2021-02-07 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2021-02-08 Continued to Special Session 1 in Health, Welfare and Institutions
- 2021-02-16 House committee, floor amendments and substitutes offered
- 2021-02-16 Reported from Health, Welfare and Institutions with substitute (21-Y 0-N)
committee-passage - 2021-02-16 Committee substitute printed 21104492D-H1
substitution - 2021-02-17 Impact statement from DPB (SB1333H1)
- 2021-02-18 Read second time
reading-2 - 2021-02-19 Read third time
reading-3 - 2021-02-19 Passed by temporarily
- 2021-02-19 Committee substitute agreed to 21104492D-H1
- 2021-02-19 Engrossed by House - committee substitute SB1333H1
- 2021-02-19 Passed House with substitute (87-Y 9-N 2-A)
passage - 2021-02-19 VOTE: Passage (87-Y 9-N 2-A)
- 2021-02-23 House substitute agreed to by Senate (34-Y 5-N)
- 2021-02-23 Title replaced 21104492D-H1
- 2021-02-25 Enrolled
- 2021-02-25 Impact statement from DPB (SB1333ER)
- 2021-02-25 Signed by President
- 2021-02-26 Signed by Speaker
- 2021-03-01 Enrolled Bill Communicated to Governor on March 1, 2021
- 2021-03-01 Governor's Action Deadline 11:59 p.m., March 31, 2021
- 2021-03-18 Approved by Governor-Chapter 228 (effective 7/1/21)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1dd12eca-aa41-4a3c-a0d3-363f9519763c. Confidence: reported (aggregated from official Virginia legislature records).